Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Want To Avoid Food Poisoning? Skip These Items At Your Hotel's Breakfast Buffet
HuffPost· 2 hours agoAs for juices, both fresh and pasteurized should be cold. Since fresh juice isn’t pasteurized,...
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya...
Benzinga· 4 hours agoFollowing the initial analysis up to Day 29 post-vaccination, the most recent analysis of study VLA1553-321 evaluated the safety and immunogenicity six months (Day 180) after ...
Do Electrolytes Give You Energy?
Verywell Health via Yahoo News· 6 days agoBicarbonate is vital to your body's pH balance and removing carbon dioxide. Overall, having these electrolytes in balance helps sustain your energy...
BioAtla gets FDA nod for new cancer drug trial By Investing.com
Investing.com· 7 days agoBioAtla, Inc. (NASDAQ:BCAB), a biotechnology firm specializing in the development of antibody...
Nut recall as "life-threatening" warning issued
Newsweek· 4 days agoA nut recall was issued this week alongside warnings of a possible "life-threatening" allergic reaction. On Wednesday, the U.S. Food and Drug< ...
How incentives could better treat stimulant use disorder
Medical Xpress· 3 days agoAlthough research has been underway for more than three decades to develop medications for people...
Zai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by...
Benzinga· 9 hours agoThe approval is based on the pivotal TRIDENT-1 trial, in which AUGTYRO achieved a high response rate and durable responses, including robust intracranial responses Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) today
Altimmune Inc (ALT) Reports Q1 2024 Financials: A Detailed Review
GuruFocus.com via Yahoo Finance· 3 days agoThe company is preparing for an End-of-Phase 2 meeting with the U.S. Food and Drug Administration...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Digital Journal· 3 days ago(NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President